On September 12, 2014, Messrs. Paul E. Freiman's and Charles S. Ramat's appointments as interim Co-Chief Executive Officers of Neurotrope, Inc. terminated effective on such date. Additionally on September 12, 2014, Mr. Ramat's appointment as Co-Chairman of the company's Board of Directors terminated on such date.

Mr. Ramat will remain a member of the Board. Mr. Freiman remains the sole Chairman of the Board. On September 12, 2014, the Board appointed Mr. Ramat to serve as the Company's President, effective as of such date.

Mr. Ramat was appointed to serve as Co-Chief Executive Officer, on an interim basis, on July 16, 2014, and he served in such capacity until September 12, 2014 when he was appointed President. Mr. Ramat was elected to the Board on June 13, 2014 and was immediately appointed Co-Chairman of the Board. Mr. Ramat served as Co-Chairman of the Board from June 13, 2014 through September 12, 2014.

Mr. Ramat is currently a private investor and has operational and general business experience in several industries including: biotechnology, medical devices, commercial finance, real estate and mobile communications.